Palatin Looking Up

Palatin Technologies is looking up on news that AstraZeneca (AZN) has signed an obesity drug deal with Palatin Technologies (PTN). The deal could earn Palatin up to $300 million. Palatin is also developing an inhaled drug for sexual dysfunction for men and women. I mentioned this company a while back and I still feel strongly about this stock.